Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David S Rickman

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
Blood|November 2, 2006
Gene-expression profiling of systemic anaplastic large-cell lymphoma reveals differences based on ALK status and two distinct morphologic ALK+ subtypesLaurence Lamant, Aurélien de Reyniès, Marie-Michèle Duplantier, et al.
Haematologica|May 30, 2013
CD30-positive peripheral T-cell lymphomas share molecular and phenotypic featuresBettina Bisig, Aurélien de Reyniès, Christophe Bonnet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 14, 2009
Gene expression profiling reveals a new classification of adrenocortical tumors and identifies molecular predictors of malignancy and survivalAurélien de Reyniès, Guillaume Assié, David S Rickman, et al.
Developmental Cell|June 3, 2006
Apc tumor suppressor gene is the "zonation-keeper" of mouse liverSamira Benhamouche, Thomas Decaens, Cécile Godard, et al.
Cold Spring Harbor Molecular Case Studies|September 3, 2017
A germline FANCA alteration that is associated with increased sensitivity to DNA damaging agentsDavid C Wilkes, Verena Sailer, Hui Xue, et al.
Cell Reports|June 7, 2016
A Computational Drug Repositioning Approach for Targeting Oncogenic Transcription FactorsKaitlyn M Gayvert, Etienne Dardenne, Cynthia Cheung, et al.
American Journal of Clinical Pathology|September 19, 2009
In situ evidence of KRAS amplification and association with increased p21 levels in non-small cell lung carcinomaPatrick L Wagner, Sven Perner, David S Rickman, et al.
Genome Biology|July 29, 2017
Identification of novel prostate cancer drivers using RegNetDriver: a framework for integration of genetic and epigenetic alterations with tissue-specific regulatory networkPriyanka Dhingra, Alexander Martinez-Fundichely, Adeline Berger, et al.
Cancer Research|March 19, 2009
SLC45A3-ELK4 is a novel and frequent erythroblast transformation-specific fusion transcript in prostate cancerDavid S Rickman, Dorothee Pflueger, Benjamin Moss, et al.
Elife|July 18, 2022
AR-V7 exhibits non-canonical mechanisms of nuclear import and chromatin engagement in castrate-resistant prostate cancerSeaho Kim, CheukMan C Au, Mohd Azrin Bin Jamalruddin, et al.
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
Blood|November 2, 2006
Gene-expression profiling of systemic anaplastic large-cell lymphoma reveals differences based on ALK status and two distinct morphologic ALK+ subtypesLaurence Lamant, Aurélien de Reyniès, Marie-Michèle Duplantier, et al.
Haematologica|May 30, 2013
CD30-positive peripheral T-cell lymphomas share molecular and phenotypic featuresBettina Bisig, Aurélien de Reyniès, Christophe Bonnet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 14, 2009
Gene expression profiling reveals a new classification of adrenocortical tumors and identifies molecular predictors of malignancy and survivalAurélien de Reyniès, Guillaume Assié, David S Rickman, et al.
Developmental Cell|June 3, 2006
Apc tumor suppressor gene is the "zonation-keeper" of mouse liverSamira Benhamouche, Thomas Decaens, Cécile Godard, et al.
Cold Spring Harbor Molecular Case Studies|September 3, 2017
A germline FANCA alteration that is associated with increased sensitivity to DNA damaging agentsDavid C Wilkes, Verena Sailer, Hui Xue, et al.
Cell Reports|June 7, 2016
A Computational Drug Repositioning Approach for Targeting Oncogenic Transcription FactorsKaitlyn M Gayvert, Etienne Dardenne, Cynthia Cheung, et al.
American Journal of Clinical Pathology|September 19, 2009
In situ evidence of KRAS amplification and association with increased p21 levels in non-small cell lung carcinomaPatrick L Wagner, Sven Perner, David S Rickman, et al.
Genome Biology|July 29, 2017
Identification of novel prostate cancer drivers using RegNetDriver: a framework for integration of genetic and epigenetic alterations with tissue-specific regulatory networkPriyanka Dhingra, Alexander Martinez-Fundichely, Adeline Berger, et al.
Cancer Research|March 19, 2009
SLC45A3-ELK4 is a novel and frequent erythroblast transformation-specific fusion transcript in prostate cancerDavid S Rickman, Dorothee Pflueger, Benjamin Moss, et al.
Elife|July 18, 2022
AR-V7 exhibits non-canonical mechanisms of nuclear import and chromatin engagement in castrate-resistant prostate cancerSeaho Kim, CheukMan C Au, Mohd Azrin Bin Jamalruddin, et al.
Pageof 6